These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29046238)

  • 61. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
    Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF NEW FUSED TRIAZINE DERIVATIVES BASED ON 6-METHYL-3-THIOXO-1,2,4-TRIAZIN-5-ONE.
    Abd El-All AS; Hassan AS; Osman SA; Yosef HA; Abdel-Hady WH; El-Hashash MA; Atta-Allah SR; Ali MM; El Rashedy AA
    Acta Pol Pharm; 2016; 73(1):79-92. PubMed ID: 27008803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
    Saczewski F; Maruszak M; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis of some new heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anti-cancer drugs, Part II.
    Abdel-Rahman RM; Morsy JM; el-Edfawy S; Amine HA
    Pharmazie; 1999 Sep; 54(9):667-71. PubMed ID: 10522270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities.
    Kanti Das S; Mishra S; Manna K; Kayal U; Mahapatra S; Das Saha K; Dalapati S; Das GP; Mostafa AA; Bhaumik A
    Chem Commun (Camb); 2018 Oct; 54(81):11475-11478. PubMed ID: 30256355
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Privileged s-triazines: structure and pharmacological applications.
    Shah DR; Modh RP; Chikhalia KH
    Future Med Chem; 2014 Mar; 6(4):463-77. PubMed ID: 24635525
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New One-Pot Synthesis of 1,3,5-Triazines: Three-Component Condensation, Dimroth Rearrangement, and Dehydrogenative Aromatization.
    Junaid A; Lim FPL; Tiekink ERT; Dolzhenko AV
    ACS Comb Sci; 2019 Jul; 21(7):548-555. PubMed ID: 31180634
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro antitumor activity evaluation of some 1,2,4-triazine derivatives bearing piperazine amide moiety against breast cancer cells.
    Yurttaş L; Demirayak S; Ilgın S; Atlı Ö
    Bioorg Med Chem; 2014 Nov; 22(22):6313-23. PubMed ID: 25438754
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Triazine-benzimidazole hybrids: anticancer activity, DNA interaction and dihydrofolate reductase inhibitors.
    Singla P; Luxami V; Paul K
    Bioorg Med Chem; 2015 Apr; 23(8):1691-700. PubMed ID: 25792141
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors.
    Borzilleri RM; Zheng X; Qian L; Ellis C; Cai ZW; Wautlet BS; Mortillo S; Jeyaseelan R; Kukral DW; Fura A; Kamath A; Vyas V; Tokarski JS; Barrish JC; Hunt JT; Lombardo LJ; Fargnoli J; Bhide RS
    J Med Chem; 2005 Jun; 48(12):3991-4008. PubMed ID: 15943473
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors.
    Paquin I; Raeppel S; Leit S; Gaudette F; Zhou N; Moradei O; Saavedra O; Bernstein N; Raeppel F; Bouchain G; Fréchette S; Woo SH; Vaisburg A; Fournel M; Kalita A; Robert MF; Lu A; Trachy-Bourget MC; Yan PT; Liu J; Rahil J; MacLeod AR; Besterman JM; Li Z; Delorme D
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1067-71. PubMed ID: 18160287
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
    Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
    Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis of some new heterobicyclic compounds containing spiro-1,2,4-triazine moiety as potential anti HIV and anticancer agents.
    Abdel-Rahman RM; Seada M; Fawzy M; el-Baz I
    Boll Chim Farm; 1994 Jun; 133(6):374-80. PubMed ID: 7917184
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
    Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V
    Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents.
    Katiyar SB; Srivastava K; Puri SK; Chauhan PM
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4957-60. PubMed ID: 16168643
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
    El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
    Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and chemistry of fluorine containing bioactive 1,2,4-triazines--an overview. Chemistry of uncondensed 1,2,4-triazines, Part III.
    Abdel-Rahman RM
    Pharmazie; 1999 Nov; 54(11):791-803. PubMed ID: 10603605
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
    Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
    Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recent updates on 1,2,3-, 1,2,4-, and 1,3,5-triazine hybrids (2017-present): The anticancer activity, structure-activity relationships, and mechanisms of action.
    Dong G; Jiang Y; Zhang F; Zhu F; Liu J; Xu Z
    Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200479. PubMed ID: 36372519
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis of 1,3-thiazine-2,4-diones with potential anticancer activity.
    Ferreira M; Assunção LS; Filippin-Monteiro FB; Creczynski-Pasa TB; Sá MM
    Eur J Med Chem; 2013; 70():411-8. PubMed ID: 24177368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.